Fulcrum Therapeutics Garners $55,000,000 Series A Funding

  • Feed Type
  • Date
    7/21/2016
  • Company Name
    Fulcrum Therapeutics
  • Mailing Address
    One Kendall Square Cambridge, MA 02139 USA
  • Company Description
    We are here to develop new medicines to deliver a new future for patients and their families by transforming gene regulation in disease. Above all we are champions for our patients. Trust, Respect, Compassion and Integrity define who we are.
  • Website
    http://www.fulcrumtx.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $55,000,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    Proceeds purposes were notFulcrum Therapeutics to develop new medicines to deliver a new future to patients and their families by transforming gene regulation in disease. disclosed.
  • M&A Terms
  • Venture Investor
    Third Rock Ventures
  • Venture Investor
    Undisclosed

Trending on Xconomy